性感染症(STD)診断の世界市場:主要国別シェア、セグメント予測

【英語タイトル】Global Sexually-Transmitted Diseases (STD) Market Country Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Suppliers

Venture Planning Groupが出版した調査資料(VPMD801033)・商品コード:VPMD801033
・発行会社(調査会社):Venture Planning Group
・発行日:2017年12月28日
・ページ数:350
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Local PDF(同一国内共有可)USD9,600 ⇒換算¥1,084,800見積依頼/購入/質問フォーム
Global PDF(複数国内共有可)USD21,100 ⇒換算¥2,384,300見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales forecasts by country and market segment, including:

     – Hospitals
     – Commercial/Private Labs
     – Physician Offices
     – Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

     -  Reviews features and operating characteristics of major analyzers used 
        for STD testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies, 
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.

Contains 350 pages and 90 tables

【レポートの目次】

※目次は次のURLでご確認いただけます。
http://www.vpgcorp.com/webfiles/INFECTIOUSDISEASEPDF/TOCTOT%20CompetingintheGlobalSexuallyTransmittedDiseasesTestingMarketETTechAsssInstMarketSharesSFStrategicProfiles.pdf
http://www.vpgmarketresearch.com/pdffiles/LOTSexuallyTransmittedDiseasesGlobalMarketOutlookandEmergingOpportunities.pdf



【掲載企業】

Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako


★調査レポート[性感染症(STD)診断の世界市場:主要国別シェア、セグメント予測] (コード:VPMD801033)販売に関する免責事項を必ずご確認ください。
★調査レポート[性感染症(STD)診断の世界市場:主要国別シェア、セグメント予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆